Zhu L, Jiang B, Fei X, Xu Y, et al. Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy. Radiology 2025;317:e251698.
PMID: 41400470